UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

6ER-022 Clinical impact of the use of glucocorticoids for the treatment of COVID-19 in intermediate respiratory care units

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A165-A166

2023

Link zum Volltext

Verfügbarkeit prüfen

4CPS-074 Efficacy and safety of sotrovimab: results of a retrospective observational study in a French Hospital

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A48-A48

2023

Link zum Volltext

Verfügbarkeit prüfen

4CPS-148 Use of remdesivir in severe SARS-CoV-2 pneumonia in critically and non-critically ill patients

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A78-A78

2022

Link zum Volltext

Verfügbarkeit prüfen

4CPS-314 3 day course of low dose subcutaneous anakinra in patients with refractory moderate–severe COVID-19: a proof-of-concept study

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A71-A72

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-233 Home management of acute multiple sclerosis outbreak: adaptation to coronavirus pandemic

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A32-A32

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-338 Use and efficacy of tocilizumab in patients with severe COVID-19 pneumonia

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A83-A84

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-171 Tocilizumab in patients with COVID-19: results in clinical practice

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A140-A140

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-219 Comparison of the number of parental nutrition prescriptions in 2020 during the COVID-19 pandemic with the same time period in 2019

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A24-A25

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-348 The hospital pharmacy in the creation of clean circuits in the face of COVID-19

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A88-A89

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-357 Clinical characteristics and mortality of COVID-19 in a long term care facility

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A92-A93

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-379 Parenteral nutrition management in coronavirus critical patients: case report

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A103-A103

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-296 Impact of the COVID-19 pandemic on clinical lung cancer management

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A63-A63

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-402 COVID-19 and digestive surgery: medical devices for surgical smoke filtration

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A114-A114

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-321 Anakinra in severe COVID-19 pneumonia: retrospective study

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A75-A75

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-246 Coronavirus first wave effect on antibiotic consumption and antimicrobial resistance

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A38-A38

2021

Link zum Volltext

Verfügbarkeit prüfen

Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results

European journal of hospital pharmacy. Science and practice, 2023-01, Vol.30 (1), p.e1-e1

2023

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-058 Efficacy and marginal cost of treatment with tocilizumab in COVID-19 patients

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A138-A138

2022

Link zum Volltext

Verfügbarkeit prüfen

4CPS-108 Biomarkers evolution in patients with SARS-CoV-2 pneumonia treated with baricitinib

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A64-A65

2022

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-002 Adverse events reported after administration of BNT162B2 and mRNA-1273 COVID-19 vaccines among healthcare workers

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A199-A199

2022

Link zum Volltext

Verfügbarkeit prüfen

6ER-013 Analysis of patients’ mortality in SARS-CoV-2 infection during the first month of hospital admission

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A206-A207

2022

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-078 Analysis of casirivimab and imdevimab use in outpatients with covid-19

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A139-A139

2023

Link zum Volltext

Verfügbarkeit prüfen

4CPS-191 Impact of the COVID-19 pandemic on the adherence of HIV patients

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A86-A87

2023

Link zum Volltext

Verfügbarkeit prüfen

4CPS-123 Case-control study on the association between nosocomial bloodstream infections and glucocorticoids, tocilizumab, systemic antibiotics, mechanical ventilation and length of hospital stay in COVID-19 hospitalised patients

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A64-A64

2023

Link zum Volltext

Verfügbarkeit prüfen

4CPS-004 Trends in treatments during COVID-19 pandemic in a university tertiary hospital

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A24-A24

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-004 Effectiveness and safety of COVID-19 vaccination in patients with immune-mediated diseases on biological therapy

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A161-A161

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 61

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBmj Global Health

KollektionBMJ Journals

Zeitschrift / SerieEuropean Journal Of Hospital Pharmacy. Science And Practice

ThemaSevere Acute Respiratory Syndrome Coronavirus 2

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(61)

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(61)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(61)
BMJ Publishing
(61)
MEDLINE
(21)

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

6ER-022 Clinical impact of the use of glucocorticoids for the treatment of COVID-19 in intermediate respiratory care units

4CPS-074 Efficacy and safety of sotrovimab: results of a retrospective observational study in a French Hospital

4CPS-148 Use of remdesivir in severe SARS-CoV-2 pneumonia in critically and non-critically ill patients

4CPS-314 3 day course of low dose subcutaneous anakinra in patients with refractory moderate–severe COVID-19: a proof-of-concept study

4CPS-233 Home management of acute multiple sclerosis outbreak: adaptation to coronavirus pandemic

4CPS-338 Use and efficacy of tocilizumab in patients with severe COVID-19 pneumonia

5PSQ-171 Tocilizumab in patients with COVID-19: results in clinical practice

4CPS-219 Comparison of the number of parental nutrition prescriptions in 2020 during the COVID-19 pandemic with the same time period in 2019

4CPS-348 The hospital pharmacy in the creation of clean circuits in the face of COVID-19

4CPS-357 Clinical characteristics and mortality of COVID-19 in a long term care facility

4CPS-379 Parenteral nutrition management in coronavirus critical patients: case report

4CPS-296 Impact of the COVID-19 pandemic on clinical lung cancer management

4CPS-402 COVID-19 and digestive surgery: medical devices for surgical smoke filtration

4CPS-321 Anakinra in severe COVID-19 pneumonia: retrospective study

4CPS-246 Coronavirus first wave effect on antibiotic consumption and antimicrobial resistance

Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results

5PSQ-058 Efficacy and marginal cost of treatment with tocilizumab in COVID-19 patients

4CPS-108 Biomarkers evolution in patients with SARS-CoV-2 pneumonia treated with baricitinib

5PSQ-002 Adverse events reported after administration of BNT162B2 and mRNA-1273 COVID-19 vaccines among healthcare workers

6ER-013 Analysis of patients’ mortality in SARS-CoV-2 infection during the first month of hospital admission

5PSQ-078 Analysis of casirivimab and imdevimab use in outpatients with covid-19

4CPS-191 Impact of the COVID-19 pandemic on the adherence of HIV patients

4CPS-123 Case-control study on the association between nosocomial bloodstream infections and glucocorticoids, tocilizumab, systemic antibiotics, mechanical ventilation and length of hospital stay in COVID-19 hospitalised patients

4CPS-004 Trends in treatments during COVID-19 pandemic in a university tertiary hospital

6ER-004 Effectiveness and safety of COVID-19 vaccination in patients with immune-mediated diseases on biological therapy

Aktive Filter

Suchergebnisse filtern